628 antibodies registered
| Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
|---|---|---|---|---|
| AN0204 | 12E3 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>5 |
| AN0203 | 1E6 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n=2 |
| AN0200 | 2-2B | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>4 |
| AN0206 | 5A5 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>3 |
| AN0190 | 735 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>11 |
| AN0205 | H.46 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>8 |
| AN0191 | OL28 | EP0101 | Poly-N-Acetylneuraminic Acid | (Neu5Ac)n n>4 |
| AN0128 | S2-566 | EP0101 | Poly-N-Acetylneuraminic Acid | Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R |
| AN0407 | 2-4B | EP0102 | Poly-N-Glycolylneuraminic Acid | (Neu5Gc)n n>2 |
| AN0202 | AC1 | EP0102 | Poly-N-Glycolylneuraminic Acid | (Neu5Gc)n n=4-5 |
| AN0207 | kdn8kdn | EP0103 | Poly-KDN | (KDN)n n>2 |
| AN0303 | kdn3G | EP0104 | KDN-Gal | KDN(a2-3)Gal(b1-)-R KDN9Ac(a2-3)Gal(b1-)-R |
| AN0436 | KA-17 | EP0110 | GD1 alpha(Pentasaccharide) | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)Gal-R |
| AN0347 | anti-Chol-1 alpha | EP0111 | GT1a alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| AN0435 | GGR41 / GGR-41 | EP0111 | GT1a alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| AN0347 | anti-Chol-1 alpha | EP0112 | GQ1b alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| AN0435 | GGR41 / GGR-41 | EP0112 | GQ1b alpha | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| AN0489 | MC2102 | EP0113 | Galabiosylceramide | Gal(a1-4)Gal(b1-1)Cer |
| AN0582 | 11-50 | EP0114 | Lactotetraosylceramide | Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
| AN0583 | HMST-1 | EP0114 | Lactotetraosylceramide | Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
| AN0656 | NMD-1 | EP0115 | 2-9,2-6 Disialyllactosylceramide | Neu5Ac(a2-9)Neu5Ac(a2-6)Gal(b1-4)Glc(b1-1)Cer |
| AN0505 | AIC3IA2 | EP0120 | SM4s | HSO3(-3)Gal(b1-1)Cer |
| AN0662 | AIC3IB3 | EP0120 | SM4s | HSO3(-3)Gal(b1-1)Cer |
| AN0463 | anti-I Ma | EP0138 | I Antigen | Gal(b1-4)GlcNAc(b1-6)Gal-R |
| AN0464 | anti-I Woj | EP0138 | I Antigen | Gal(b1-4)GlcNAc(b1-6)Gal-R |